| Literature DB >> 24116703 |
Cheng Pei1, Mark Barbour, Karen J Fairlie-Clarke, Debbie Allan, Rong Mu, Hui-Rong Jiang.
Abstract
Interleukin-33 (IL-33) is a member of the IL-1 cytokine family. It predominantly induces type 2 immune responses and thus is protective against atherosclerosis and nematode infections but contributes to allergic airway inflammation. Interleukin-33 also plays a pivotal role in the development of many autoimmune diseases through mechanisms that are still not fully understood. In this review, we focus on the recent advances in understanding of the expression and function of IL-33 in some autoimmune disorders, aiming to provide insight into its potential role in disease development.Entities:
Keywords: ST2; autoimmune diseases; inflammation; interleukin-33
Mesh:
Substances:
Year: 2014 PMID: 24116703 PMCID: PMC3893845 DOI: 10.1111/imm.12174
Source DB: PubMed Journal: Immunology ISSN: 0019-2805 Impact factor: 7.397